Principal Investigator
Estelamari Rodriguez
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20231091
Clinical Trial Summary
A Randomized, Double-blind, Multi-center, Phase III Study of AK112 or Placebo Combined with Pemetrexed and Carboplatin in Patients with EGFR-mutant Locally Advanced or Metastatic Non-squamous NSCLC Who Have Failed to EGFR-TKI Treatment (HARMONi)
Phase
Phase III
Funding Agency/Sponsor
Industrial
Disease
Thoracic Oncology
Contact Information
Phone Number
305-243-2647